Bright Minds Biosciences Inc. (DRUG)
USD 38.03
(-4.33%)
USD 38.03
(-4.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -7.02 Million | -13.58 Million | -7.31 Million | -288.39 Thousand | -42 Thousand |
| Net Income | -7.37 Million | -14.96 Million | -8.65 Million | -480.37 Thousand | -78.71 Thousand |
| Depreciation & Amortization | 72.45 Thousand | 6037.00 | - | - | - |
| Deferred income taxes | 45.34 Thousand | - | - | - | - |
| Stock-based compensation | 1.15 Million | 875.05 Thousand | 880.61 Thousand | 161.3 Thousand | - |
| Change in working capital | -941.71 Thousand | 726.3 Thousand | 306.08 Thousand | 30.68 Thousand | 36.7 Thousand |
| Other non-cash items | 19.75 Thousand | -229.57 Thousand | 144.76 Thousand | 161.3 Thousand | 110.12 Thousand |
| Investing Cash Flow | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - |
| Financing Cash Flow | 2.18 Million | 5.19 Million | 26.05 Million | 1 Million | 122 Thousand |
| Debt repayment | -86.11 Thousand | -7162.00 | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 1.21 Million | 4.03 Million | 27.74 Million | 1 Million | 122 Thousand |
| Other Financing Activities | 1.05 Million | 1.16 Million | -1.68 Million | 1008.33 | 366 Thousand |
| Accounts receivables | 118.79 Thousand | -45.63 Thousand | -110.14 Thousand | - | - |
| Accounts payables | - | 765.98 Billion | 506.15 Billion | - | - |
| Inventory | - | 45.63 Thousand | 110.14 Thousand | - | - |
| Other working capital | -1.06 Million | -765.98 Billion | -506.14 Billion | 30.68 Thousand | 36.7 Thousand |
| Cash at beginning of period | 11.62 Million | 19.76 Million | 799.92 Thousand | 79.99 Thousand | - |
| Cash at end of period | 6.74 Million | 11.62 Million | 19.76 Million | 799.92 Thousand | 79.99 Thousand |
| Capital Expenditure | - | - | - | - | - |
| Effect of forex changes on cash | -45.34 Thousand | 258.82 Thousand | 223.78 Thousand | - | - |
| Net cash flow / Change in cash | -4.87 Million | -8.13 Million | 18.96 Million | 719.93 Thousand | 79.99 Thousand |
| Free Cash Flow | -7.02 Million | -13.58 Million | -7.31 Million | -288.39 Thousand | -42 Thousand |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 229.9 Thousand | -574.14 Thousand | -1.68 Million | -1.52 Million | -7.37 Million | -1.45 Million |
| Depreciation & Amortization | 18.11 Thousand | 18.11 Thousand | 18.11 Thousand | 18.11 Thousand | 72.45 Thousand | 18.11 Thousand |
| Deferred income taxes | - | - | -263.23 Thousand | 163.43 Thousand | 45.34 Thousand | -130.47 Thousand |
| Stock-based compensation | 183.94 Thousand | 226.64 Thousand | 218.94 Thousand | 400.49 Thousand | 1.15 Million | 237.53 Thousand |
| Change in working capital | -153.43 Thousand | -479.99 Thousand | 579.85 Thousand | -255.35 Thousand | -941.71 Thousand | -322 Thousand |
| Other non-cash items | -354.21 Thousand | 775.36 Thousand | 308.5 Thousand | 3786.00 | 19.75 Thousand | 4576.00 |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -21.95 Thousand | -21.95 Thousand | 878.04 Thousand | -21.64 Thousand | 2.18 Million | -21.48 Thousand |
| Debt repayment | -21.95 Thousand | -21.95 Thousand | -21.95 Thousand | -21.64 Thousand | -86.11 Thousand | -21.48 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 900 Thousand | - | 1.21 Million | - |
| Other Financing Activities | - | - | 900.00 | -21.65 | 1.05 Million | -21.49 |
| Accounts receivables | 536.01 Thousand | -508.2 Thousand | -8059.00 | 66.69 Thousand | 118.79 Thousand | -70.31 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -689.44 Thousand | 28.21 Thousand | 587.91 Thousand | -322.05 Thousand | -1.06 Million | -251.68 Thousand |
| Cash at beginning of period | 5.84 Million | 6.67 Million | 6.66 Million | 8.13 Million | 11.62 Million | 9.67 Million |
| Cash at end of period | 6.1 Million | 5.84 Million | 6.67 Million | 6.74 Million | 6.74 Million | 8.13 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 39.6 Thousand | -2165.00 | -42.29 Thousand | -163.43 Thousand | -45.34 Thousand | 130.47 Thousand |
| Net cash flow / Change in cash | 257.8 Thousand | -829.21 Thousand | 13.66 Thousand | -1.38 Million | -4.87 Million | -1.54 Million |
| Free Cash Flow | 240.16 Thousand | -805.08 Thousand | -822.08 Thousand | -1.19 Million | -7.02 Million | -1.65 Million |
HAIN
3090
8377
BSX
VSTTILLERS
TRIP